临床误诊误治
臨床誤診誤治
림상오진오치
CLINICAL MISDIAGNOSIS & MISTHERAPY
2014年
11期
1-4
,共4页
蓝海峰%杨文忠%姜虹%贾新颜%高勇
藍海峰%楊文忠%薑虹%賈新顏%高勇
람해봉%양문충%강홍%가신안%고용
白血病,早幼粒细胞,急性%Ph染色体阳性%误诊%白血病,粒单核细胞,急性
白血病,早幼粒細胞,急性%Ph染色體暘性%誤診%白血病,粒單覈細胞,急性
백혈병,조유립세포,급성%Ph염색체양성%오진%백혈병,립단핵세포,급성
Leukemia,promyelocytic,acute,positive%Philadelphia chromosome%Diagnostic errors%Leukemia,myelomonocytic,acute
目的:探讨伴Ph染色体阳性急性早幼粒细胞白血病( acute promyelocytic leukemia, APL)的临床特征及诊治措施,以减少误诊误治。方法回顾性分析我院收治的1例骨髓形态、免疫组织化学及免疫表型极似急性粒单核细胞白血病且Ph染色体阳性APL的临床资料。结果本例因发热3周余就诊,根据骨髓形态学、免疫组织化学及免疫分型结果,初诊为急性粒单核细胞白血病,给予标准IDA方案(伊达比星加阿糖胞苷)化学治疗效果不佳。复查骨髓形态学并结合细胞遗传学检查,确诊为伴Ph染色体阳性APL,经维A酸( ATRA)联合三氧化二砷( ATO)治疗达完全缓解( CR),巩固治疗4个疗程。随访8个月仍处于CR,PML-RARA融合基因转阴,但BCR-ABL融合基因仍阳性。结论细胞遗传学检查应作为拟诊急性白血病患者的必要检查,可减少误诊,提高治疗效果。
目的:探討伴Ph染色體暘性急性早幼粒細胞白血病( acute promyelocytic leukemia, APL)的臨床特徵及診治措施,以減少誤診誤治。方法迴顧性分析我院收治的1例骨髓形態、免疫組織化學及免疫錶型極似急性粒單覈細胞白血病且Ph染色體暘性APL的臨床資料。結果本例因髮熱3週餘就診,根據骨髓形態學、免疫組織化學及免疫分型結果,初診為急性粒單覈細胞白血病,給予標準IDA方案(伊達比星加阿糖胞苷)化學治療效果不佳。複查骨髓形態學併結閤細胞遺傳學檢查,確診為伴Ph染色體暘性APL,經維A痠( ATRA)聯閤三氧化二砷( ATO)治療達完全緩解( CR),鞏固治療4箇療程。隨訪8箇月仍處于CR,PML-RARA融閤基因轉陰,但BCR-ABL融閤基因仍暘性。結論細胞遺傳學檢查應作為擬診急性白血病患者的必要檢查,可減少誤診,提高治療效果。
목적:탐토반Ph염색체양성급성조유립세포백혈병( acute promyelocytic leukemia, APL)적림상특정급진치조시,이감소오진오치。방법회고성분석아원수치적1례골수형태、면역조직화학급면역표형겁사급성립단핵세포백혈병차Ph염색체양성APL적림상자료。결과본례인발열3주여취진,근거골수형태학、면역조직화학급면역분형결과,초진위급성립단핵세포백혈병,급여표준IDA방안(이체비성가아당포감)화학치료효과불가。복사골수형태학병결합세포유전학검사,학진위반Ph염색체양성APL,경유A산( ATRA)연합삼양화이신( ATO)치료체완전완해( CR),공고치료4개료정。수방8개월잉처우CR,PML-RARA융합기인전음,단BCR-ABL융합기인잉양성。결론세포유전학검사응작위의진급성백혈병환자적필요검사,가감소오진,제고치료효과。
Objective To explore the clinical features, diagnosis and treatment of acute promyelocytic leukemia ( APL) with philadelphia chromosome ( Ph) positivity in order to avoid misdiagnosis and mistreatment. Methods Clinical data of a patient with Ph-positive acute promyelocytic leukemia manifesting as acute myelomonocytic leukemia was retrospec-tively analyzed, and related literature was reviewed. Results The patient was admitted for fever over three weeks. Primary diagnosis was acute myelomonocytic leukemia after examinations of morphologic, immunophenotypic and histochemistry. But the standard IDA regimen was ineffective, which used idarubicin and cytarabine. APL with positive Ph was confirmed by cyto-genetics and morphologic studies. Complete remission was obtained after treatment with all-trans-retinoic acid ( ATRA) and arsenic trioxide ( ATO) . There was no evidence of recurrence for 8 months after 4 cycles of consolidation therapy. PML-RARA fusion gene was changed to be negative, but BCR-ABL fusion gene was still positive. Conclusion Cytogenetic examination for suspected acute leukemia patients is necessary to reduce misdiagnosis and improve the therapeutic effect.